Tumor microenvironments, the immune system and cancer survival

Genome Biology

Volumn 6, Issue 3, 2005, Pages

  Strausberg, Robert L ^a  

^a J CRAIG VENTER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD2 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; CELL MARKER; GENE PRODUCT; TUMOR ANTIGEN;

BIOINFORMATICS; CANCER CELL; CANCER IMMUNOLOGY; CANCER RESEARCH; CANCER SURVIVAL; DNA MICROARRAY; FOLLICULAR LYMPHOMA; GENE EXPRESSION; HUMAN; IMMUNE SYSTEM; LARGE CELL LYMPHOMA; MICROENVIRONMENT; PROGNOSIS; SHORT SURVEY;

CELL TRANSFORMATION, NEOPLASTIC; COMPUTATIONAL BIOLOGY; DISEASE PROGRESSION; HUMANS; IMMUNE SYSTEM; KILLER CELLS, NATURAL; MACROPHAGES; MODELS, BIOLOGICAL; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; T-LYMPHOCYTES;

EID: 16844371719     PISSN: 14656906     EISSN: None     Source Type: Journal    
DOI: 10.1186/gb-2005-6-3-211     Document Type: Short Survey

References (31)

1. Dunn GP, Old LJ, Schreiber RD: The three Es of cancer immunoediting. Annu Rev Immunol 2004, 22:329-360.
2. Dunn GP, Old LJ, Schreiber RD: The immunobiology of cancer immunosurveillance and immunoediting. Immunity 2004, 21: 37-148.
3. + T cell responses to MAGE-3 protein in lung cancer patients. J Immunol 2004, 172:3289-3296.
4. Emens LA, Jaffee EM: Cancer vaccines: an old idea comes of age. Cancer Biol Ther 2003, 2 Suppl 1:S161-168.
5. Jakobisiak M, Lasek W, Golab J: Natural mechanisms protecting against cancer. Immunol Lett 2003, 90:103-122.
6. Jungbluth AA, Stockert E, Huang HJ, Collins VP, Coplan K, Iversen K, Kolb D, Johns TJ, Scott AM, Gullick WJ, et al.: A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor. Proc Natl Acad Sci USA 2003, 100:639-644.
7. Odunsi K, Jungbluth AA, Stockert E, Qian F, Gnjatic S, Tammela J, Intengan M, Beck A, Keitz B, Santiago D, et al.: NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer. Cancer Res 2003, 63:6076-6083.
8. Radvanyi L: Discovery and immunologic validation of new antigens for therapeutic cancer vaccines. Int Arch Allergy Immunol 2004, 133:179-197.
9. Scanlan MJ, Gure AO, Jungbluth AA, Old LJ, Chen YT: Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev 2002, 188:22-32.
10. Zbar AP: The immunology of colorectal cancer. Surg Oncol 2004, 13:45-53.
11. Dave SS, Wright G, Tan B, Rosenwald A, Gascoyne RD, Chan WC, Fisher RI, Braziel RM, Rimsza LM, Grogan TM, et al.: Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. New Engl J Med 2004, 351: 159-2169.
12. Monti S, Savage KJ, Kutok JL, Feuerhake F, Kurtin P, Mihm M, Wu B, Pasqualucci L, Neuberg D, Aguiar RC, et al.: Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood 2005, 105:1851-1861.
13. Burnet F: The concept of immunological surveillance. Prog Exp Tumor Res 1970, 13:1-27.
14. Alizadeh A, Eisen M, Davis R, Ma C, Lossos I, Rosenwald A, Boldrick J, Sabet H, Tran T, Yu X, et al.: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403:503-511.
15. Davis RE, Staudt LM: Molecular diagnosis of lymphoid malignancies by gene expression profiling. Curr Opin Hematol 2002, 9:333-338.
16. Gascoyne RD, Dave S, Zettl A, Bea S, Chan WC, Rosenwald A, Jaffe ES, Campo E, Delabie J, Weisenburger D et al.: Gene expression microarray analysis of de novo CDS(+) diffuse large B-cell lymphoma (LLMPP study): a distinct entity? Blood 2003, 102:178A-179A.
17. Rosenwald A, Staudt LM: Gene expression profiling of diffuse large B-cell lymphoma. Leuk Lymphoma 2003, 44: 41-S47.
18. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002, 346:1937-1947.
19. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, et al.: Molecular portraits of human breast tumours. Nature 2000, 406: 47-752.
20. Ramaswamy S, Perou CM: DNA microarrays in breast cancer: the promise of personalised medicine. Lancet 2003, 361: 576-1577.
21. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, et al.: Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 2003, 100:8418-8423.
22. Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P, Ladd C, Beheshti J, Bueno R, Gillette M, et a.: Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 2001, 98:13790-13795.
23. Golub TR: Genome-wide views of cancer. N Engl J Med 2001, 344:601-602.
24. Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG, Ladd C, Pohl U, Hartmann C, McLaughlin ME, Batchelor TT, et al.: Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res 2003, 63:1602-1607.
25. Iqbal J, Sanger WG, Horsman DE, Rosenwald A, Pickering DL, Dave B, Dave S, Xiao L, Cao K, Zhu Q, et al.: BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma. Am J Pathol 2004, 165: 59-166.
26. Staudt LM: Molecular diagnosis of cancer by gene expression profiling. Eur J Cancer 2002, 38:S3-S4.
27. Zettl A, Bea S, Rosenwald A, Jehn P, Salaverria I, Ott G, Staudt LM, Chan WC, Jaffe ES, Weisenburger DD, et al.: Different subtypes of diffuse large B-cell lymphoma defined by gene expression profiling are genetically distinct. Blood 2003, 102: 78A-178A.
28. Chiba T, Ohtani H, Mizoi T, Naito Y, Sato E, Nagura H, Ohuchi A, Ohuchi K, Shiiba K, Kurokawa Y, et al: Intraepithelial CD8(+) T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma: possible association with suppression of micrometastasis. Brit J Cancer 2004, 91:1711-1717.
29. Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, Makrigiannakis A, Gray H, Schlienger K, Liebman MN, et al.: Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 2003, 348:203-213.
30. Riccobon A, Gunelli R, Ridolfi R, De Paola F, Flamini E, Fiori M, Saltutti C, Petrini M, Fiammenghi L, Stefanelli M, et al.: Immuno-suppression in renal cancer: differential expression of signal transduction molecules in tumor-infiltrating, near-tumor tissue, and peripheral blood lymphocytes. Cancer Invest 2004, 22: 71-877.
31. Zhou J, Dudley ME, Rosenberg SA, Robbins PF: Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy. J Immunother 2005, 28:53-62.